跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
善思达 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Paliperidone Palmitate Injection
Approved
化学药品
Paliperidone Palmitate Injection
Janssen-Cilag International NV
🇨🇳 National Medical Products Administration
Approval Date
Aug 27, 2021
Approval ID
8DqcDsN4rww
Company
Janssen-Cilag International NV
Type
化学药品
Approval Details
Approval Id
8DqcDsN4rww
Approval Number
国药准字HJ20160642
Generic Name
棕榈酸帕利哌酮注射液
Generic Name En
Paliperidone Palmitate Injection
Trade Name
善思达
Drug Type
化学药品
Dosage Form
注射剂
Strength
0.75ml:75mg
Reg Date
2021-08-27
Expired Date
2026-08-26
Company Name
Janssen-Cilag International NV
Company Detail Path
/organization/janssen-cilag-international-nv
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Aug 27, 2021
Approval ID
8DqcDsN4rww
Type
化学药品
Back to NMPA Approvals